Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis

被引:72
作者
Li, Xintao [1 ,2 ]
Chan, Jeffrey Shi Kai [2 ]
Guan, Bo [3 ]
Peng, Shi [1 ]
Wu, Xiaoyu [1 ]
Lu, Xiaofeng [1 ]
Zhou, Jiandong [2 ,5 ]
Hui, Jeremy Man Ho [2 ]
Lee, Yan Hiu Athena [2 ]
Satti, Danish Iltaf [2 ]
Tsang, Shek Long [2 ]
Wu, Shouling [4 ]
Chen, Songwen [1 ]
Tse, Gary [2 ,6 ,7 ]
Liu, Shaowen [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Cardiol, Shanghai 200080, Peoples R China
[2] Cardiovasc Analyt Grp, Epidmiol Res Unit, Hong Kong, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Geriatr Cardiol Dept, Natl Clin Res Ctr Geriatr Dis, Med Ctr 2, Beijing, Peoples R China
[4] Kailuan Gen Hosp, Dept Cardiol, Tangshan 063000, Peoples R China
[5] Univ Oxford, Nuffield Dept Med, Oxford, England
[6] Kent & Medway Med Sch, Canterbury CT2 7NT, Kent, England
[7] Tianjin Med Univ, Tianjin Inst Cardiol, Tianjin Key Lab Ionic Mol Funct Cardiovasc Dis, Hosp 2,Dept Cardiol, Tianjin 300211, Peoples R China
基金
中国国家自然科学基金;
关键词
Heart failure; Triglyceride-glucose index; Risk stratification; Mendelian randomization; Insulin resistance; INSULIN-RESISTANCE; CARDIOVASCULAR OUTCOMES; ASSOCIATION; POPULATION; EPIDEMIOLOGY; METAANALYSIS; DISEASE; OBESITY; HEALTH;
D O I
10.1186/s12933-022-01658-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The relationship between triglyceride-glucose (TyG) index, an emerging marker of insulin resistance, and the risk of incident heart failure (HF) was unclear. This study thus aimed to investigate this relationship. Methods Subjects without prevalent cardiovascular diseases from the prospective Kailuan cohort (recruited during 2006-2007) and a retrospective cohort of family medicine patients from Hong Kong (recruited during 2000-2003) were followed up until December 31st, 2019 for the outcome of incident HF. Separate adjusted hazard ratios (aHRs) summarizing the relationship between TyG index and HF risk in the two cohorts were combined using a random-effect meta-analysis. Additionally, a two-sample Mendelian randomization (MR) of published genome-wide association study data was performed to assess the causality of observed associations. Results In total, 95,996 and 19,345 subjects from the Kailuan and Hong Kong cohorts were analyzed, respectively, with 2,726 cases of incident HF in the former and 1,709 in the latter. Subjects in the highest quartile of TyG index had the highest risk of incident HF in both cohorts (Kailuan: aHR 1.23 (95% confidence interval: 1.09-1.39), P-T(ren)d <0.001; Hong Kong: aHR 1.21 (1.04-1.40), P-Trend = 0.007; both compared with the lowest quartile). Meta-analysis showed similar results (highest versus lowest quartile: HR 1.22 (1.11-1.34), P < 0.001). Findings from MR analysis, which included 47,309 cases and 930,014 controls, supported a causal relationship between higher TyG index and increased risk of HF (odds ratio 1.27 (1.15-1.40), P < 0.001). Conclusion A higher TyG index is an independent and causal risk factor for incident HF in the general population.
引用
收藏
页数:12
相关论文
共 51 条
  • [1] How can we measure insulin sensitivity/resistance?
    Antuna-Puente, B.
    Disse, E.
    Rabasa-Lhoret, R.
    Laville, M.
    Capeau, J.
    Bastard, J. -P.
    [J]. DIABETES & METABOLISM, 2011, 37 (03) : 179 - 188
  • [2] Insulin Resistance and Risk of Incident Heart Failure Cardiovascular Health Study
    Banerjee, Dipanjan
    Biggs, Mary L.
    Mercer, Laina
    Mukamal, Kenneth
    Kaplan, Robert
    Barzilay, Joshua
    Kuller, Lewis
    Kizer, Jorge R.
    Djousse, Luc
    Tracy, Russell
    Zieman, Susan
    Lloyd-Jones, Donald
    Siscovick, David
    Carnethon, Mercedes
    [J]. CIRCULATION-HEART FAILURE, 2013, 6 (03) : 364 - 370
  • [3] Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors
    Burgess, Stephen
    Scott, Robert A.
    Timpson, Nicholas J.
    Smith, George Davey
    Thompson, Simon G.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (07) : 543 - 552
  • [4] High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study
    Chan, Jeffrey Shi Kai
    Satti, Danish Iltaf
    Lee, Yan Hiu Athena
    Hui, Jeremy Man Ho
    Lee, Teddy Tai Loy
    Chou, Oscar Hou In
    Wai, Abraham Ka Chung
    Ciobanu, Ana
    Liu, Ying
    Liu, Tong
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Zhang, Qingpeng
    Cheung, Bernard Man Yung
    Zhou, Jiandong
    Tse, Gary
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (14) : E323 - E325
  • [5] Chan JSK, 2022, CURR PROB CARDIOLOGY
  • [6] Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
    de Boer, Rudolf A.
    Nayor, Matthew
    deFilippi, Christopher R.
    Enserro, Danielle
    Bhambhani, Vijeta
    Kizer, Jorge R.
    Blaha, Michael J.
    Brouwers, Frank P.
    Cushman, Mary
    Lima, Joao A. C.
    Bahrami, Hossein
    van der Harst, Pim
    Wang, Thomas J.
    Gansevoort, Ron T.
    Fox, Caroline S.
    Gaggin, Hanna K.
    Kop, Willem J.
    Liu, Kiang
    Vasan, Ramachandran S.
    Psaty, Bruce M.
    Lee, Douglas S.
    Hillege, Hans L.
    Bartz, Traci M.
    Benjamin, Emelia J.
    Chan, Cheeling
    Allison, Matthew
    Gardin, Julius M.
    Januzzi, James L., Jr.
    Shah, Sanjiv J.
    Levy, Daniel
    Herrington, David M.
    Larson, Martin G.
    van Gilst, Wiek H.
    Gottdiener, John S.
    Bertoni, Alain G.
    Ho, Jennifer E.
    [J]. JAMA CARDIOLOGY, 2018, 3 (03) : 215 - 224
  • [7] Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
    Ding, Xiaobo
    Wang, Xiaozhen
    Wu, Jing
    Zhang, Manli
    Cui, Meizi
    [J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [8] Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
    Evangelou, Evangelos
    Warren, Helen R.
    Mosen-Ansorena, David
    Mifsu, Borbala
    Pazoki, Raha
    Gao, He
    Ntritsos, Georgios
    Dimou, Niki
    Cabrer, Claudia P.
    Karaman, Ibrahim
    Ng, FuLiang
    Evangelou, Marina
    Witkowska, Katarzyna
    Tzanis, Evan
    Hellwege, Jacklyn N.
    Giri, Ayush
    Edwards, Digna R. Velez
    Sun, Yan, V
    Cho, Kelly
    Gaziano, J. Michael
    Wilson, Peter W. F.
    Tsao, Philip S.
    Kovesdy, Csaba P.
    Esko, Tonu
    Magi, Reedik
    Milani, Lili
    Almgren, Peter
    Boutin, Thibaud
    Debette, Stephanie
    Ding, Jun
    Giulianini, Franco
    Holliday, Elizabeth G.
    Jackson, Anne U.
    Li-Gao, Ruifang
    Lin, Wei-Yu
    Luan, Jian'an
    Mangino, Massimo
    Oldmeadow, Christopher
    Prins, Bram Peter
    Qian, Yong
    Sargurupremraj, Muralidharan
    Shah, Nabi
    Surendran, Praveen
    Theriault, Sebastien
    Verweij, Niek
    Willems, Sara M.
    Zhao, Jing-Hua
    Amouyel, Philippe
    Connell, John
    de Mutsert, Renee
    [J]. NATURE GENETICS, 2018, 50 (10) : 1412 - +
  • [9] Sex differences in cardiometabolic disorders
    Gerdts, Eva
    Regitz-Zagrosek, Vera
    [J]. NATURE MEDICINE, 2019, 25 (11) : 1657 - 1666
  • [10] Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus: Lost in Translation Between Clinical Trial Design, Regulatory Standards, and Practice Guidelines
    Greene, Stephen J.
    Butler, Javed
    [J]. CIRCULATION, 2019, 139 (02) : 152 - 154